Which symptoms are associated with EPS from haloperidol? 

Questions

Which symptоms аre аssоciаted with EPS frоm haloperidol? 

The fоllоwing аdverse events аre repоrted for the innovаtor product in its approved Professional Information: 4.8 Undesirable effects Frequency categories are defined as: Very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1 000 to < 1/100); rare (≥ 1/10 000 to < 1/1 000); very rare (< 1/10 000). Table 1: Adverse reactions reported in phase 2 and phase 3 controlled trials    System organ classes Very common Common Uncommon Rare     Immune system disorders       Anaphylactic reaction    Metabolism and nutrition disorders   Hypoglycaemia Dehydration      Psychiatric disorders   Insomnia        Nervous system   DizzinessDysgeusia        Cardiac disorders     Tachycardia      Gastrointestinal disorders Nausea Vomiting Diarrhoea Constipation Dry mouthDyspepsiaGastritisGastro-oesophageal reflux disease Pancreatitis      Hepatobiliary disorders   Cholelithiasis Cholecystitis      Skin and subcutaneous tissue disorders     Urticaria      Renal andUrinary disorders       Acute renal failureRenal impairment    General disorders and administration site conditions   Injection site reactionsAstheniaFatigue Malaise   Transcribe this information for the Professional Information of a generic product. (10) Note: In the interest of time, a tabulated format need not be used.